Where does Medasense Biometrics Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Medasense Biometrics Ltd. ranks #18,884 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Medasense Biometrics Ltd. hold?

Medasense Biometrics Ltd. holds 15 US utility patents granted between 2016 and 2025, spanning 5 technology areas.

What is Medasense Biometrics Ltd.'s Innovation Score?

Medasense Biometrics Ltd. has an Innovation Score of 32.4 out of 100 (41st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Medasense Biometrics Ltd. focus on?

Medasense Biometrics Ltd.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 12 patents, ranking #1,451 of 7,127 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Medasense Biometrics Ltd.'s patent grant rate increasing or decreasing?

Medasense Biometrics Ltd.'s recent grant velocity is +80% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Medasense Biometrics Ltd.'s patents?

Medasense Biometrics Ltd.'s patents average 11.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Medasense Biometrics Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medasense Biometrics Ltd.

USPTO PatentsView assignee record - 15 granted patents across 5 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Medasense ranks #18,884 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 5 technology areas.

#18,884
of 49,997 US assignees by volume: 41st percentile
by Innovation Score (32.4/100): 11.6
avg claims per patent: +80%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18884 · Foreign Corporation #18,884 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 15 grants
MID-PACK #18,884/49,997
PHOTO-FINISH Mastronardi Produce
CPC-NARROW A61B · 5 areas
INNOV-THIN 32.4/100
CLAIMS-PAR 11.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +80% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mastronardi Produce Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Medasense’s 32.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (30%) Velocity 8.0 pts (25%) Breadth 7.9 pts (24%) Claim depth 7.0 pts (22%)

Qualcomm Incorporated · highest

85
Medasense Biometrics · this assignee

32
3D Lighting… · lowest

7

What this shows Medasense's Innovation Score is 32.4/100 (41st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Medasense?

Each dot is one of Medasense’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medasense’s own 11.6 claims/patent is ABOVE the 8.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Medasense vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Medasense's grants concentrate

Medasense Biometrics Ltd. is a focused PatentsView assignee: 5 CPC subclasses with 80% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2016. By volume, Medasense sits between Mastronardi Produce Ltd. and Metgen OY.

Medasense's three-year grant acceleration

Medasense Biometrics Ltd. shows 6 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Mastronardi Produ…

15
Material Science

15
Mayser

15
Mechanix Wear

15
Megmilk Snow Brand

15
Merck Kgaa

15
Mertek Industries

15
Metgen OY

15
Medasense Biometr… ◀

15

What this shows Medasense holds 15 patents at rank #18,873, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Medasense

By rank, the assignees closest to #18,873 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Medasense's primary technology class.

Medasense's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 41st percentile higher than 41% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Medasense Biometrics Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	6.7%
2018	2	13.3%
2019	2	13.3%
2020	1	6.7%
2021	2	13.3%
2022	1	6.7%
2023	2	13.3%
2024	3	20.0%
2025partial year	1	6.7%

Which technologies does Medasense Biometrics Ltd. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 12

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 8

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 4

G06N - Computing Arrangements Based ON Specific Computational Models 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Medasense Biometrics Ltd.'s patent record in context - here's where to go next.

Medasense Biometrics Ltd.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 80% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #18,884 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Medasense Biometrics Ltd. against Mastronardi Produce Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.